Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

31results about How to "Modulated release rate" patented technology

Anti-infection biological ceramic artificial bone and application thereof

The invention provides an anti-infection biological ceramic artificial bone and application thereof. The artificial bone is prepared by the following method that biological ceramics, bioglass sintering auxiliary agents and bonding agents are mixed; the obtained mixture is formed to obtain a composite blank body; the bioglass sintering auxiliary agents are selected from silicate glass and/or phosphate glass; antibacterial ions and bone vascularization promotion ions are mixed in the bioglass sintering auxiliary agents; the antibacterial ions are selected from one or several kinds of materials from silver, gallium, copper and zinc; the bone vascularization promotion ions are selected from one or several kinds of materials from magnesium, strontium, iron, boron, cobalt and lithium; the total amount of substances of oxides of the antibacterial ions and oxides of the bone vascularization promotion ions accounts for 0.1 to 60 percent of the amount of substance of the bioglass sintering auxiliary agents; the mol ratio of the antibacterial ions to the bone vascularization promotion ions is (0.05 to 20):1; the composite blank body is sintered to obtain the biological ceramic artificial bone. The anti-infection biological ceramic artificial bone has the advantages of high intensity and low cell toxicity; the antibacterial ion release speed is controllable; the release time is long.
Owner:GUANGDONG UNIV OF TECH

Absorbable magnesium alloy staple having antibiosis and anti-inflammation functions, and making method thereof

The invention relates to an absorbable magnesium alloy staple having antibiosis and anti-inflammation functions, and a making method thereof. The staple is composed of a pure magnesium or magnesium alloy wire core with the surface containing a porous ceramic layer, an intermediate functional layer loaded with anti-inflammation medicines and copper ions with gelatin as a carrier, and a degradable high-molecular external surface layer. The copper ions and the anti-inflammation medicines are effectively loaded on the surface of the wire with gelatin as the carrier by adopting an electrophoresis-electrodeposition process, and the external surface layer of the staple is a degradable high-molecular layer having a protection effect. The staple can slowly release the copper ions having a sterilizing effect and the anti-inflammation medicines having an anti-inflammation effect in the use process. Additionally, the synergistic effect between the intermediate functional layer with the gelatin as the carrier and the external degradable high-molecular layer realizes the effective control of the medicine release rate and the staple degradation speed. The staple can be widely applied to the stitching or inosculation of the intestine, the stomach and other human body different positions, and has a wide application prospect.
Owner:SOUTHEAST UNIV

Efficient slow-release fertilizer for Armeniaca sibirica on hillside dry land and preparation method thereof

InactiveCN105294294ARich pore sizeReduce the rate of degradation and disintegrationFertilizer mixturesChelated zincMesoporous silica
The invention belongs to the field of slow release fertilizer, and specifically discloses an efficient slow-release fertilizer for Armeniaca sibirica on hillside dry land. The fertilizer is characterized by including the following components by weight: micron calcined broiled fish bone meal, attapulgite clay, polyacrylamide, mesoporous silica nanoparticles, tamarind polysaccharide, konjac polysaccharide, calcium stearate, sodium oleate, chelated zinc, maleic anhydride, organic acid chelated titanium, medium trace element, Ginkgo biloba fermented powder, eucommia leaf fermented powder, fly maggot powder, and sugar residue. Attapulgite clay, tamarind polysaccharide and konjac polysaccharide are chelated to prepare a water absorbing and holding of slow -release coating material; while materials of different sizes are added to enrich the pore size of the coating material, control the nutrient release rate, reduce the degradation rate of the coating material, and prolong the fertilizer efficiency. The Ginkgo biloba leaf fermented powder, eucommia leaf fermented powder, fly maggot powder and sugar residue provide rich nutrition for Armeniaca sibirica and promote the efficient cultivation of Armeniaca sibirica.
Owner:HEFEI YONGSHENG CULTIVATION CO LTD

Lipid-protein edible double-layer active membrane and preparation method thereof

The invention discloses a lipid-protein edible double-layer active membrane and a preparation method thereof. The preparation method comprises the following steps: respectively dissolving an alcohol-soluble protein and a water-soluble protein in an acetic acid-water solution, and adding a hydrophobic active substance into the alcohol-soluble protein and / or adding a hydrophilic active substance into the water-soluble protein to respectively obtain an alcohol-soluble protein solution and a water-soluble protein solution; uniformly mixing the alcohol-soluble protein solution with the water-soluble protein solution, and adding a plasticizer; and mixing the film forming solution with solid lipid, heating to a temperature being equal to or higher than the melting point of the lipid, carrying outhigh-speed shearing homogenization to form an emulsion, and casting to form the membrane. The preparation method is simple and convenient, and the protein-lipid double-layer active membrane can be prepared through one-time tape casting, so the drying time can be shortened, and the production efficiency can be improved. The active membrane has a good one-way water blocking effect and good mechanical properties, and the release rate of an active matter can be regulated by regulating the ratio of the alcohol-soluble protein to the water-soluble protein and the mass percentage of the lipid.
Owner:SOUTH CHINA AGRI UNIV

Traditional Chinese medicine composition and plaster used for treating vertebra column and vertebra lumbalis and preparation method and application of plaster

The invention discloses a traditional Chinese medicine composition and plaster used for treating vertebra column and vertebra lumbalis and a preparation method and application of plaster, and relatesto the field of Chinese herbal medicine. The traditional Chinese medicine composition used for treating vertebral column and vertebra lumbalis contains the following crude drugs in parts by weight: 30-50 parts of caulis spatholobi, 5-15 parts of safflower carthamus, 10-30 parts of eucommia ulmoides, 20-40 parts of rhizoma atractylodis macrocephalae, 15-25 parts of radix Clematidis, 20-40 parts ofradix paeoniae alba, 5-15 parts of frankincense, 20-40 parts of poria cocos, 10-30 parts of fructus psoraleae, 25-35 parts of papaya, 5-15 parts of myrrh, 15-25 parts of Chinese polyphaga, 15-25 partsof paniculate swallowwort root, 10-20 parts of radix angelicae pubescentis, 30-50 parts of polygonum cuspidatum, 25-35 parts of Chinese starjasmine stem, 15-25 parts of zaocys dhumnades, and 15-25 parts of radix stephaniae tetrandrae. The traditional Chinese medicine composition, by reasonable compatibility of the components, has a good treatment effect for old strain, lumbar muscle strain and vertebral column or lumbar vertebrae injuries, and is low in cost and fast to take effect.
Owner:何传乾

Cabazitaxel-oligo/polylactic acid conjugated prodrug, preparation, preparation method and application thereof

The invention discloses a cabazitaxel oligo / polylactic acid coupled prodrug and a preparation method thereof. The preparation method is characterized in that cabazitaxel and oligo / polylactic acid undergo an esterification reaction under the action of a condensing agent and a catalyst to obtain the cabazitaxel oligo / polylactic acid coupled prodrug. The invention also discloses a cabazitaxel-oligo / polylactic acid coupled prodrug preparation, and a preparation method and an application thereof. The oligo / polylactic acid is covalently coupled with cabazitaxel, so the in vivo release rate of cabazitaxel is can be regulated, the precipitation of cabazitaxel, caused by strong release, is prevented, the in vivo cycle period of the cabazitaxel is prolonged, and the maximum tolerable dose is increased. The oligo / polylactic acid is approved for use by the US FDA and has an excellent application prospect. The cabazitaxel oligo / polylactic acid prodrug and an amphiphilic polymer PEG5k-PLA8k are assembled to form nanoparticles, and the nanoparticles have a passive targeting effect, and are easily retained in the tumor site by the EPR effect in order to greatly reduce the toxic and side effects ofthe drug on normal tissues.
Owner:ZHEJIANG UNIV

Camptothecin-polycaprolactone coupling prodrug, preparation method thereof, preparation, and preparation method and application of preparation

The invention discloses a camptothecin-polycaprolactone coupling prodrug, a preparation method thereof, a preparation, and a preparation method and application of the preparation. According to the invention, the camptothecin polycaprolactone coupling prodrug is obtained by esterification of a camptothecin drug and polycaprolactone. According to the invention, polycaprolactone is covalently coupled with camptothecin or 7-ethyl-10-hydroxycamptothecine, so that the release rate of camptothecine active molecules in vivo can be regulated and controlled, the camptothecine active molecules are prevented from being separated out due to burst release, and the circulation time of the camptothecine active molecules in vivo is prolonged. Meanwhile, polycaprolactone is approved to be used in the market by FDA in America, and has a good application prospect. The camptothecin-polycaprolactone prodrug and an auxiliary agent are assembled to form nanoparticles, the nanoparticles have a passive targeting effect, and can be retained at a tumor site through an EPR effect to reduce exposure to normal tissues, so that the anti-tumor effect of the drug is greatly improved, and the in-vivo side effects are reduced.
Owner:ZHEJIANG UNIV

Cabazitaxel-oligo/polylactic acid coupled prodrug, preparation thereof, preparation method and application of preparation

The invention discloses a cabazitaxel oligo/polylactic acid coupled prodrug and a preparation method thereof. The preparation method is characterized in that cabazitaxel and oligo/polylactic acid undergo an esterification reaction under the action of a condensing agent and a catalyst to obtain the cabazitaxel oligo/polylactic acid coupled prodrug. The invention also discloses a cabazitaxel-oligo/polylactic acid coupled prodrug preparation, and a preparation method and an application thereof. The oligo/polylactic acid is covalently coupled with cabazitaxel, so the in vivo release rate of cabazitaxel is can be regulated, the precipitation of cabazitaxel, caused by strong release, is prevented, the in vivo cycle period of the cabazitaxel is prolonged, and the maximum tolerable dose is increased. The oligo/polylactic acid is approved for use by the US FDA and has an excellent application prospect. The cabazitaxel oligo/polylactic acid prodrug and an amphiphilic polymer PEG5k-PLA8k are assembled to form nanoparticles, and the nanoparticles have a passive targeting effect, and are easily retained in the tumor site by the EPR effect in order to greatly reduce the toxic and side effects ofthe drug on normal tissues.
Owner:ZHEJIANG UNIV

A kind of anti-infection bioceramic artificial bone and its application

The invention provides an anti-infection biological ceramic artificial bone and application thereof. The artificial bone is prepared by the following method that biological ceramics, bioglass sintering auxiliary agents and bonding agents are mixed; the obtained mixture is formed to obtain a composite blank body; the bioglass sintering auxiliary agents are selected from silicate glass and / or phosphate glass; antibacterial ions and bone vascularization promotion ions are mixed in the bioglass sintering auxiliary agents; the antibacterial ions are selected from one or several kinds of materials from silver, gallium, copper and zinc; the bone vascularization promotion ions are selected from one or several kinds of materials from magnesium, strontium, iron, boron, cobalt and lithium; the total amount of substances of oxides of the antibacterial ions and oxides of the bone vascularization promotion ions accounts for 0.1 to 60 percent of the amount of substance of the bioglass sintering auxiliary agents; the mol ratio of the antibacterial ions to the bone vascularization promotion ions is (0.05 to 20):1; the composite blank body is sintered to obtain the biological ceramic artificial bone. The anti-infection biological ceramic artificial bone has the advantages of high intensity and low cell toxicity; the antibacterial ion release speed is controllable; the release time is long.
Owner:GUANGDONG UNIV OF TECH

Hollow hydroxyapatite microspheres with controllable pore size, preparation method and application thereof

The invention provides a hollow hydroxyapatite microsphere with a controllable bore diameter. The grain size of the microsphere is 400nm-7000nm; the microsphere surface has a thorn-shaped structure; a hollow structure is formed in the microsphere; and the crystal form is hydroxyapatite. The preparation method for the microsphere mainly comprises the following steps: preparing a calcium carbonate precursor, performing hydrothermal reaction and marking with rhodamine. The invention also researches an application of the microsphere in the field of a drug-loading slow release. After the invention researches the drug-loading efficiency, degradation rate and release rule of the microsphere prepared from lauryl sodium sulfate in different concentrations, a conclusion proves that the acquired hollow hydroxyapatite microsphere can achieve the most ideal drug-loading and drug-release effects when the concentration of the lauryl sodium sulfate is a critical micelle concentration. Besides, the invention innovatively realizes the combination of the microsphere with the rhodamine dye through an amino group on the surface of the hollow hydroxyapatite microsphere, so that the drug-loading microsphere is more easily positioned and traced in biological performance evaluation and action mechanism research.
Owner:乔威 +2

Sodium nitrite-gelatin microsphere and preparation method and application thereof

The invention discloses a sodium nitrite-gelatin microsphere and a preparation method and application thereof. The preparation method comprises the following steps of: firstly, adding gelatin into deionized water, and stirring until the gelatin is completely dissolved to obtain a gelatin solution; then adding sodium nitrite into the gelatin solution, and continuously stirring until the sodium nitrite is completely dissolved to obtain a mixed solution; then adding glutamine transaminase into the mixed solution, and then stirring for reaction to obtain a cross-linked solution; then adding an emulsifier into an oil phase, then dropwise adding the cross-linked solution under the stirring condition, and continuously carrying out emulsification reaction under the stirring condition to form an emulsion; and finally, cooling the emulsion under the stirring condition, and carrying out operations such as ultrasonic treatment, suction filtration separation and washing to finally obtain the sodium nitrite-gelatin microsphere. The preparation method is simple in overall operation, and the prepared sodium nitrite-gelatin microsphere is smooth in surface and uniform in particle size, has the average particle size of 5-40 microns, can slowly release NO in a weak acidic environment, and can be applied to food antibacterial agents.
Owner:TIANJIN UNIVERSITY OF SCIENCE AND TECHNOLOGY

A pH-responsive in-situ controlled-release titanium-based implant and its preparation method and application

The invention discloses a pH-responsive in-situ controlled-release titanium-based implant, a preparation method and application thereof. In the present invention, titanium-based implants are constructed on the surface of titanium-based implants through anodic oxidation to construct titanium dioxide nanotube structures, and then dopamine is used to introduce amino reaction sites on the top of titanium dioxide nanotubes, and then PMAA is grafted to it by amide reaction. Finally, the HHC36 polypeptide with antibacterial properties was loaded to obtain a pH-responsive in situ controlled-release titanium-based implant. The pH-responsive in-situ controlled-release titanium-based implant of the present invention can respond to the pH changes of the surrounding solution, regulate the release rate of antibacterial polypeptides, and has excellent antibacterial performance. In the 4th cycle sterilization experiment, it is effective against Escherichia coli and Pseudomonas aeruginosa. , Staphylococcus aureus and methicillin-resistant Staphylococcus aureus still have a bactericidal rate of more than 99%. The pH-responsive in-situ controlled-release titanium-based implant of the present invention aims at the difficult problem of bacterial infection of clinical titanium-based implants, and can reduce the risk of bacterial infection.
Owner:SOUTH CHINA UNIV OF TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products